Case Study: Harmonization of ASEAN and EMA Requirements for a Dual Market Submission
Submitting a pharmaceutical product to multiple global markets is a regulatory challenge, especially when regions like ASEAN and the European Union have differing expectations. This case study explores a successful dual market submission that aligned the stability testing protocols of the ASEAN region (Zone IVb) with EMA’s expectations (Zone II). We examine how the company…
Read More “Case Study: Harmonization of ASEAN and EMA Requirements for a Dual Market Submission” »